Correlation Between Day One and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Day One and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Spyre Therapeutics, you can compare the effects of market volatilities on Day One and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Spyre Therapeutics.
Diversification Opportunities for Day One and Spyre Therapeutics
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Day and Spyre is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Day One i.e., Day One and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Day One and Spyre Therapeutics
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.64 times more return on investment than Spyre Therapeutics. However, Day One Biopharmaceuticals is 1.56 times less risky than Spyre Therapeutics. It trades about -0.27 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.37 per unit of risk. If you would invest 1,485 in Day One Biopharmaceuticals on September 14, 2024 and sell it today you would lose (204.00) from holding Day One Biopharmaceuticals or give up 13.74% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Spyre Therapeutics
Performance |
| Timeline |
| Day One Biopharmaceu |
| Spyre Therapeutics |
Day One and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Spyre Therapeutics
The main advantage of trading using opposite Day One and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Spyre Therapeutics vs. Puma Biotechnology | Spyre Therapeutics vs. Iovance Biotherapeutics | Spyre Therapeutics vs. Day One Biopharmaceuticals | Spyre Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |